CME Webcast Discusses Emergency Surgical Conditions

OSUWexnerbloglogo2014 CME Webcast Discusses Emergency Surgical Conditions. On this CME webcast, we’re going to talk about common surgical emergencies: how they present, how you diagnosis them, and how you treat them. Joining our moderator in the studio is Assistant Professor of Emergency Medicine, Dr. Mike Barrie. And also, joining him, will be Professor of Surgery and the Chief of the OSU Division of Trauma, Critical Care, and Burn Surgery, Dr. Steven Steinberg.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY emergent surgical conditions that present as abdominal pain; UNDERSTAND the importance of involving a surgeon early in the evaluation and management of acute abdominal problems; DISCUSS the diagnosis and early management of emergent surgical conditions; PROVIDE practical knowledge for the primary care provider to manage patients with emergent surgical conditions.

You’ll also learn about the following:

  • When imaging is warranted in patients with abdominal complaints
  • When to call the surgeon
  • When to do pregnancy testing
  • Common causes of abdominal pain in young women
  • Presentation of large bowel versus small bowel obstruction
  • Intestinal diameter: How big is too big?
  • Vulnerable parts of the bowel for perforation
  • Ultrasound in the emergency room
  • Massive transfusion protocols in the emergency department

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

New Developments in Lung Cancer Treatment

OSUWexnerbloglogo2014 New Developments in Lung Cancer Treatment. Lung cancer now accounts for 14% of all cancers but it is the most common cause of cancer death, In fact, more people die each year from lung cancer than from colon cancer, breast cancer, and prostate cancer combined. The 5-year survival rate of lung cancer is only 18% but the good news is that we have a lot of new medications that are giving patients with lung cancer longer and better lives. On our CME webcast, to discuss new treatments in lung cancer, are two of Ohio State’s experts in the management of lung cancer. Joining our moderator, Dr. Jim Allen, we have Dr. Greg Otterson who is a Professor of Internal Medicine from the Division of Medical Oncology and Dr. Erin Bertino, an Assistant Professor of Internal Medicine, also from the Division of Medical Oncology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: GAIN an understanding of the importance of genomic testing in the initial workup of patients with lung cancer. EXPLAIN the evolving role of immune mediated therapy in lung cancer; RECOGNIZE the clinical benefit for patients receiving targeted therapies; and DESCRIBE the patient characteristics commonly associated with actionable mutations in lung cancer.

You’ll also learn about the following:

  • The most fatal of all common cancers
  • Evolving chemotherapy treatment of lung cancer
  • Sub-classifying adenocarcinomas
  • Squamous cell lung cancer treatment
  • Large cell undifferentiated lung cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.